Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Discordance between Etravirine Phenotype and Genotype-based Predicted Phenotype for Subtype C HIV-1 from First-line Antiretroviral Therapy Failures in South Africa.

McCormick KD, Penrose KJ, Brumme CJ, Harrigan R, Viana RV, Mellors JW, Parikh UM, Wallis CL.

Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02101-19. doi: 10.1128/AAC.02101-19. [Epub ahead of print]

PMID:
32071061
2.

Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000-2015.

Gabai CM, Moore MS, Penrose K, Braunstein S, Bocour A, Neaigus A, Winters A.

Sex Transm Infect. 2019 Dec 4. pii: sextrans-2019-054208. doi: 10.1136/sextrans-2019-054208. [Epub ahead of print]

PMID:
31801894
3.

Impact of an HIV Care Coordination Program on the Timeliness of Viral Suppression and Immune Recovery Among Clients Newly Diagnosed with HIV.

Robertson MM, Penrose K, Nash D, Harriman G, Braunstein SL, Levin B, Irvine MK.

AIDS Behav. 2019 Nov 14. doi: 10.1007/s10461-019-02732-0. [Epub ahead of print]

PMID:
31728695
4.

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.

Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL.

J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282.

5.

Cost-effectiveness of HIV care coordination scale-up among persons at high risk for sub-optimal HIV care outcomes.

Stevens ER, Nucifora KA, Irvine MK, Penrose K, Robertson M, Kulkarni S, Robbins R, Abraham B, Nash D, Braithwaite RS.

PLoS One. 2019 Apr 25;14(4):e0215965. doi: 10.1371/journal.pone.0215965. eCollection 2019.

6.

Impact of an HIV Care Coordination Program on Durable Viral Suppression.

Robertson MM, Penrose K, Irvine MK, Robbins RS, Kulkarni S, Braunstein SL, Waldron L, Harriman G, Nash D.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):46-55. doi: 10.1097/QAI.0000000000001877.

7.

Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes.

Nash D, Robertson MM, Penrose K, Chamberlin S, Robbins RS, Braunstein SL, Myers JE, Abraham B, Kulkarni S, Waldron L, Levin B, Irvine MK.

PLoS One. 2018 Sep 24;13(9):e0204017. doi: 10.1371/journal.pone.0204017. eCollection 2018.

8.

Using Registry Data to Construct a Comparison Group for Programmatic Effectiveness Evaluation: The New York City HIV Care Coordination Program.

Robertson MM, Waldron L, Robbins RS, Chamberlin S, Penrose K, Levin B, Kulkarni S, Braunstein SL, Irvine MK, Nash D.

Am J Epidemiol. 2018 Sep 1;187(9):1980-1989. doi: 10.1093/aje/kwy103.

9.

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa.

Penrose KJ, Brumme CJ, Scoulos-Hanson M, Hamanishi K, Gordon K, Viana RV, Wallis CL, Harrigan PR, Mellors JW, Parikh UM.

Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618762985. doi: 10.1177/2040206618762985.

10.

Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa.

Penrose KJ, Wallis CL, Brumme CJ, Hamanishi KA, Gordon KC, Viana RV, Harrigan PR, Mellors JW, Parikh UM.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01805-16. doi: 10.1128/AAC.01805-16. Print 2017 Feb.

11.

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.

Glaubius RL, Parikh UM, Hood G, Penrose KJ, Bendavid E, Mellors JW, Abbas UL.

Open Forum Infect Dis. 2016 Jun 16;3(3):ofw125. eCollection 2016 Sep.

12.

Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.

Heffron R, Parikh UM, Penrose KJ, Mugo N, Donnell D, Celum C, Mellors JW, Baeten JM; Partners PrEP Study Team.

AIDS Behav. 2017 Jul;21(7):2173-2179. doi: 10.1007/s10461-016-1563-y.

13.

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.

Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL.

Clin Infect Dis. 2016 Aug 15;63(4):539-47. doi: 10.1093/cid/ciw321. Epub 2016 May 18.

14.

Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.

Simonetti FR, Sobolewski MD, Fyne E, Shao W, Spindler J, Hattori J, Anderson EM, Watters SA, Hill S, Wu X, Wells D, Su L, Luke BT, Halvas EK, Besson G, Penrose KJ, Yang Z, Kwan RW, Van Waes C, Uldrick T, Citrin DE, Kovacs J, Polis MA, Rehm CA, Gorelick R, Piatak M, Keele BF, Kearney MF, Coffin JM, Hughes SH, Mellors JW, Maldarelli F.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8. doi: 10.1073/pnas.1522675113. Epub 2016 Feb 8.

15.

Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA).

Penrose KJ, Parikh UM, Hamanishi KA, Else L, Back D, Boffito M, Jackson A, Mellors JW.

J Infect Dis. 2016 Mar 15;213(6):1013-7. doi: 10.1093/infdis/jiv528. Epub 2015 Nov 12.

PMID:
26563240
16.

Loss of Innate Host Defense Following Unprotected Vaginal Sex.

Nakra NA, Madan RP, Buckley N, Huber AM, Freiermuth JL, Espinoza L, Walsh J, Parikh UM, Penrose KJ, Keller MJ, Herold BC.

J Infect Dis. 2016 Mar 1;213(5):840-7. doi: 10.1093/infdis/jiv488. Epub 2015 Oct 13.

17.

Immune status of patients with inherited bone marrow failure syndromes.

Giri N, Alter BP, Penrose K, Falk RT, Pan Y, Savage SA, Williams M, Kemp TJ, Pinto LA.

Am J Hematol. 2015 Aug;90(8):702-8. doi: 10.1002/ajh.24046. Epub 2015 May 28.

18.

Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions.

Saftlas AF, Spracklen CN, Ryckman KK, Stockdale CK, Penrose K, Ault K, Rubenstein LM, Pinto LA.

J Reprod Immunol. 2015 Jun;109:74-83. doi: 10.1016/j.jri.2015.01.002. Epub 2015 Jan 30.

PMID:
25721621
19.

Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women.

Penrose KJ, Richardson BA, Besson G, Dezzutti CS, Herold BC, Abdool Karim SS, Mellors JW, Parikh UM; MTN Biomedical Sciences Working Group and the HPTN 035 Protocol Team.

Sex Transm Dis. 2014 Nov;41(11):674-9. doi: 10.1097/OLQ.0000000000000191.

20.

Delayed vesicovaginal fistula after ring pessary usage.

Penrose KJ, Ma Yin J, Tsokos N.

Int Urogynecol J. 2014 Feb;25(2):291-3. doi: 10.1007/s00192-013-2143-6. Epub 2013 Jun 26.

PMID:
23801483
21.

Health literacy, acculturation, and the use of preventive oral health care by Somali refugees living in massachusetts.

Geltman PL, Hunter Adams J, Penrose KL, Cochran J, Rybin D, Doros G, Henshaw M, Paasche-Orlow M.

J Immigr Minor Health. 2014 Aug;16(4):622-30. doi: 10.1007/s10903-013-9846-0.

22.

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Pinto LA.

Hum Vaccin Immunother. 2013 Jul;9(7):1399-406. doi: 10.4161/hv.24340. Epub 2013 Apr 9.

23.

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®).

Kemp TJ, Safaeian M, Hildesheim A, Pan Y, Penrose KJ, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA.

Vaccine. 2012 Dec 17;31(1):165-70. doi: 10.1016/j.vaccine.2012.10.067. Epub 2012 Oct 31.

24.

Vitamin D deficiency among newly resettled refugees in Massachusetts.

Penrose K, Hunter Adams J, Nguyen T, Cochran J, Geltman PL.

J Immigr Minor Health. 2012 Dec;14(6):941-8. doi: 10.1007/s10903-012-9603-9.

PMID:
22411495
25.

Women in resource-poor settings are at risk of inadequate intakes of multiple micronutrients.

Torheim LE, Ferguson EL, Penrose K, Arimond M.

J Nutr. 2010 Nov;140(11):2051S-8S. doi: 10.3945/jn.110.123463. Epub 2010 Sep 29. Review.

PMID:
20881075
26.

Informal urban settlements and cholera risk in Dar es Salaam, Tanzania.

Penrose K, de Castro MC, Werema J, Ryan ET.

PLoS Negl Trop Dis. 2010 Mar 16;4(3):e631. doi: 10.1371/journal.pntd.0000631.

27.

Psychometric properties of the Breastfeeding Self-Efficacy Scale-Short Form in an ethnically diverse U.K. sample.

Gregory A, Penrose K, Morrison C, Dennis CL, MacArthur C.

Public Health Nurs. 2008 May-Jun;25(3):278-84. doi: 10.1111/j.1525-1446.2008.00705.x.

PMID:
18477379
28.

Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy.

Dayton PA, Zhao S, Bloch SH, Schumann P, Penrose K, Matsunaga TO, Zutshi R, Doinikov A, Ferrara KW.

Mol Imaging. 2006 Jul;5(3):160-74.

29.
30.

Three-dimensional structure of a macromolecular assembly that regulates type III secretion in Yersinia pestis.

Schubot FD, Jackson MW, Penrose KJ, Cherry S, Tropea JE, Plano GV, Waugh DS.

J Mol Biol. 2005 Mar 4;346(4):1147-61. Epub 2005 Jan 20.

PMID:
15701523
31.

Casein Kinase II phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein.

Penrose KJ, Garcia-Alai M, de Prat-Gay G, McBride AA.

J Biol Chem. 2004 May 21;279(21):22430-9. Epub 2004 Mar 9.

33.

Proprioceptive neuromuscular facilitation versus weight training for enhancement of muscular strength and athletic performance*.

Nelson AG, Chambers RS, McGown CM, Penrose KW.

J Orthop Sports Phys Ther. 1986;7(5):250-3.

PMID:
18802264

Supplemental Content

Loading ...
Support Center